{"id":5998,"date":"2024-10-02T18:09:40","date_gmt":"2024-10-02T18:09:40","guid":{"rendered":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/?page_id=5998"},"modified":"2026-04-08T23:44:02","modified_gmt":"2026-04-08T23:44:02","slug":"request-for-proposal","status":"publish","type":"page","link":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/relink\/request-for-proposal\/","title":{"rendered":"Request for Proposal"},"content":{"rendered":"\n<p class=\"is-style-text-callout\">We are now accepting applications for the fourth and final round of the CDAF-Relink Grant. Please submit your application and all supporting materials to <a href=\"mailto:relink@cdafound.org\">relink@cdafound.org<\/a>. <strong>The application deadline is November 1st, 2025 (23:59 MT)<\/strong>.<\/p>\n\n\n\n<p class=\"is-style-text-callout\">The RFP, the Application Form, the Budget &amp; Timeline Form, as well as the Contract and the Data Use Agreement (that your organization is expected to sign if your application is approved) can be downloaded below. We ask all applicants to review the Contract and Data Use Agreement with their legal team before submitting their application. If the terms of these documents are not acceptable, <span style=\"text-decoration: underline;\">please do not apply<\/span>.<\/p>\n\n\n\n<p class=\"is-style-text-callout\">Register <a href=\"https:\/\/cdafound.org\/relink\/#contact-us\" data-type=\"page\" data-id=\"5935\" target=\"_blank\" rel=\"noreferrer noopener\">here <i class=\"icon fa fa-external-link\" aria-hidden=\"true\"> <\/i><\/a> for project updates. Click <a href=\"https:\/\/cdafound.org\/relink\/grantees\/\" data-type=\"page\" data-id=\"5935\" target=\"_blank\" rel=\"noreferrer noopener\">here <i class=\"icon fa fa-external-link\" aria-hidden=\"true\"> <\/i><\/a> to see our current grantees.<\/p>\n\n\n\n<p class=\"is-style-text-callout\">If you have any questions, please contact us at <a href=\"mailto:relink@cdafound.org\">relink@cdafound.org<\/a>.<\/p>\n\n\n\n<div class=\"wp-block-cdaf-download-list\"><div class=\"wp-block-cdaf-download-list__inner\">\n<section style=\"border-width:2px\" class=\"wp-block-cdaf-download has-accent-0-background-color has-background\">\n<header class=\"wp-block-cdaf-download-header\"><div class=\"wp-block-cdaf-download-header__icon-wrap\"><img decoding=\"async\" class=\"wp-block-cdaf-download-header__icon\" alt=\"\" data-id=\"5906\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/09\/PDF_file_icon.svg\"><\/div><h3 class=\"wp-block-cdaf-download-header__text\" placeholder=\"Download title\">Request for Proposal<\/h3><\/header>\n\n\n\n<div class=\"wp-block-cdaf-download-description\"><p>A RFP inviting patient advocacy groups to submit innovative strategies for improving liver health through disease awareness.<\/p><\/div>\n\n\n\n<footer class=\"wp-block-cdaf-download-footer\">\n<div class=\"wp-block-cdaf-download-buttons wp-block-buttons\">\n<div class=\"wp-block-button is-download-button is-style-fill\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/04\/CDAF-Relink-RFP-Final-250408.pdf\">Download<\/a><\/div>\n<\/div>\n\n\n\n\n<\/footer>\n<\/section>\n\n\n\n<section style=\"border-width:2px\" class=\"wp-block-cdaf-download has-accent-0-background-color has-background\">\n<header class=\"wp-block-cdaf-download-header\"><div class=\"wp-block-cdaf-download-header__icon-wrap\"><img decoding=\"async\" class=\"wp-block-cdaf-download-header__icon\" alt=\"\" data-id=\"5906\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2024\/09\/PDF_file_icon.svg\"><\/div><h3 class=\"wp-block-cdaf-download-header__text\" placeholder=\"Download title\">Agreement and DUA<\/h3><\/header>\n\n\n\n<div class=\"wp-block-cdaf-download-description\"><p>A binding legal agreement between CDA Foundation and prospective patient advocacy groups.<\/p><p>Please <strong><u>do not<\/u><\/strong> send a proposal if your organization cannot agree to the terms stated in this agreement.<\/p><\/div>\n\n\n\n<footer class=\"wp-block-cdaf-download-footer\">\n<div class=\"wp-block-cdaf-download-buttons wp-block-buttons\">\n<div class=\"wp-block-button is-download-button is-style-fill\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/04\/CDAF-Relink-Agreement-DUA-250408-1.pdf\">Download<\/a><\/div>\n<\/div>\n\n\n\n\n<\/footer>\n<\/section>\n\n\n\n<div class=\"wp-block-cdaf-download-spacer wp-block-cdaf-download-spacer__hide-small\"><\/div>\n\n\n\n<section style=\"border-width:2px\" class=\"wp-block-cdaf-download has-accent-0-background-color has-background\">\n<header class=\"wp-block-cdaf-download-header\"><div class=\"wp-block-cdaf-download-header__icon-wrap\"><img decoding=\"async\" class=\"wp-block-cdaf-download-header__icon\" alt=\"\" data-id=\"7197\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2025\/10\/ms_word.svg\"><\/div><h3 class=\"wp-block-cdaf-download-header__text\" placeholder=\"Download title\">Grant Application<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-secondary-red-color\"><strong>*<\/strong><\/mark><\/h3><\/header>\n\n\n\n<div class=\"wp-block-cdaf-download-description\"><p>The form where an applicant lays out their goals and intents.<\/p><\/div>\n\n\n\n<footer class=\"wp-block-cdaf-download-footer\">\n<div class=\"wp-block-cdaf-download-buttons wp-block-buttons\">\n<div class=\"wp-block-button is-download-button is-style-fill\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/04\/CDAF-Relink-Grant-Application-Form-Final-250408.docx\">Download<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-cdaf-download-footnote\"><p style=\"font-size:0.9rem\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-secondary-red-color\"><strong>*<\/strong><\/mark> Fill only if your organization agrees to the terms of the legal agreement<\/p><\/div>\n<\/footer>\n<\/section>\n\n\n\n<section style=\"border-width:2px\" class=\"wp-block-cdaf-download has-accent-0-background-color has-background\">\n<header class=\"wp-block-cdaf-download-header\"><div class=\"wp-block-cdaf-download-header__icon-wrap\"><img decoding=\"async\" class=\"wp-block-cdaf-download-header__icon\" alt=\"\" data-id=\"7198\" src=\"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-content\/uploads\/2025\/10\/ms_excel.svg\"><\/div><h3 class=\"wp-block-cdaf-download-header__text\" placeholder=\"Download title\">Budget &amp; Timeline<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-secondary-red-color\"><strong>*<\/strong><\/mark><\/h3><\/header>\n\n\n\n<div class=\"wp-block-cdaf-download-description\"><p>The form where an applicant lays out their timelines &amp; funding uses.<\/p><\/div>\n\n\n\n<footer class=\"wp-block-cdaf-download-footer\">\n<div class=\"wp-block-cdaf-download-buttons wp-block-buttons\">\n<div class=\"wp-block-button is-download-button is-style-fill\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2024\/08\/CDAF-Relink-Budget-Timeline-Form-240521.xlsx\">Download<\/a><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-cdaf-download-footnote\"><p style=\"font-size:0.9rem\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-secondary-red-color\"><strong>*<\/strong><\/mark> Fill only if your proposal is accepted<\/p><\/div>\n<\/footer>\n<\/section>\n<\/div><\/div>\n\n\n\n<p>Interested in past relinkage programs and studies? Click <a href=\"https:\/\/cdafound.org\/relink\/relink-resources\/\" data-type=\"page\" data-id=\"6158\" target=\"_blank\" rel=\"noreferrer noopener\">here <i class=\"icon fa fa-external-link\" aria-hidden=\"true\"> <\/i><\/a> for a resource list.<\/p>\n\n\n\n<div class=\"wp-block-cover alignfull is-light\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-accent-0-background-color has-background-dim-100 has-background-dim\"><\/span><div class=\"wp-block-cover__inner-container is-layout-constrained wp-block-cover-is-layout-constrained\">\n<h2 class=\"wp-block-heading has-text-align-center\" id=\"faq\">Frequently Asked Questions<\/h2>\n\n\n<div   class=\"wp-block-fluffle-dl\"><div class=\"wp-block-fluffle-dl-toc\" data-orientation=\"block\"><ul class=\"wp-block-fluffle-dl-toc__list\"   data-layout=\"inline-variable\"><li class=\"wp-block-fluffle-dl-toc__list-item\"><a class=\"wp-block-fluffle-dl-toc__list-link\" href=\"#fluffle-dl-1-1\">Budget<\/a><\/li><li class=\"wp-block-fluffle-dl-toc__list-item\"><a class=\"wp-block-fluffle-dl-toc__list-link\" href=\"#fluffle-dl-1-2\">Personnel<\/a><\/li><li class=\"wp-block-fluffle-dl-toc__list-item\"><a class=\"wp-block-fluffle-dl-toc__list-link\" href=\"#fluffle-dl-1-3\">Data Management<\/a><\/li><li class=\"wp-block-fluffle-dl-toc__list-item\"><a class=\"wp-block-fluffle-dl-toc__list-link\" href=\"#fluffle-dl-1-4\">Other<\/a><\/li><\/ul><div class=\"wp-block-fluffle-dl-toc__summary\"><\/div><\/div><div   data-open-mode=\"first-opened\" class=\"wp-block-fluffle-dl-body\" style=\"--fluffle-block__dl__indent-description: 25px\"><section id=\"fluffle-dl-1-1\"  data-is-open class=\"wp-block-fluffle-dl-entry\" ><div class=\"wp-block-fluffle-dl-entry-term\" ><h3 class=\"wp-block-fluffle-dl-entry-term-text\" >Budget<\/h3><\/div><div class=\"wp-block-fluffle-dl-entry-description\" ><div   class=\"wp-block-fluffle-dl is-style-boxed-inner\"><div  data-is-bulleted data-open-mode=\"all-closed\" class=\"wp-block-fluffle-dl-body\" ><details id=\"fluffle-dl-2-1\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Is there a general range or a cap for the grants?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>In Round 4, the cap is $250K.&nbsp; If the budget is over this amount, the proposal will be rejected and returned to the applicant.&nbsp; The expected range is $20\u2013250K with an average grant size of $100\u2013120K.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-2-2\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Is there an indirect cap?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>There is not.&nbsp; The advisory board discussed this and agreed that any indirect cost would be acceptable with the understanding that the project cost per individual accounts for 60% of selection criteria.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-2-3\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >How many grants will be given?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>The number of grants awarded will depend on the proposals.&nbsp; <\/p>\n<\/div><\/details><details id=\"fluffle-dl-2-4\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Is this grant funded on a calendar year basis or fiscal year?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Neither.  It can span over a calendar or fiscal year.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-2-5\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Are indirect costs available for admin?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>You can add indirect costs for admin.&nbsp; That said, a higher the total cost could increase your Cost per Individual which accounts for a significant amount of the weighting system used to select proposals.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-2-6\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Are supplies and equipment allowed (e.g., laptop, portable drive, portable devices etc.)?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>It is not forbidden but we do not recommend anything that will drive up your costs because your proposal will be judged relative to the other applicants. Thus, if another group can link the same number of people to care at a lower cost than your group, then their application will be selected over yours. Feel free to include these costs if you can maintain an efficient program.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-2-7\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Would the grant cover the cost of sending a phlebotomist to a patient&#8217;s home for a lab draw?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>No. The grant does not cover direct medical expenses related to screening or treatment. It is focused exclusively on finding already diagnosed individuals (who were lost to follow up and so remain untreated), in order to relink them to care, i.e., connecting them to a physician with whom they can review treatment options.<\/p>\n<\/div><\/details><\/div><\/div><\/div><\/section><section id=\"fluffle-dl-1-2\"  data-is-open class=\"wp-block-fluffle-dl-entry\" ><div class=\"wp-block-fluffle-dl-entry-term\" ><h3 class=\"wp-block-fluffle-dl-entry-term-text\" >Personnel<\/h3><\/div><div class=\"wp-block-fluffle-dl-entry-description\" ><div   class=\"wp-block-fluffle-dl is-style-boxed-inner\"><div data-accordion=\"multiple\" data-is-bulleted data-open-mode=\"all-closed\" class=\"wp-block-fluffle-dl-body\" ><details id=\"fluffle-dl-3-1\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Can more than one investigator be included? Relatedly, is the budget restricted to the personnel listed on the RFP (Primary Investigator, Patient Navigator, IT Manager) or was this just a suggestion?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Yes, more than one investigator may be included. There is no limit to the number of co-PIs as long as they also have tax-exempt\/??non-profit status. The budget sheet does have empty grey rows that allows applicants to add other personnel. What is listed is suggestions only.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-3-2\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Can we partner with sister organizations? We have other local smaller organizations we work closely with.<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>As long as they meet the Inclusion Criteria (Eligible State, Tax Exempt, Non-Profit, Healthcare Institution etc.), yes. For Round 4, we strongly encourage you to partner with State Health Agencies.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-3-3\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Can the patient navigator role be performed by two staff at .50FTE?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Yes.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-3-4\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >When you say \u201cphysician\u201d, does that include mid-level providers (NP, PA)?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Yes.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-3-5\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Who qualifies as primary investigator? Are they clinical leads? Can they be from QI?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Whoever we can contact to talk about the program\/?progress with. They do not have to be clinical leads.<\/p>\n<\/div><\/details><\/div><\/div><\/div><\/section><section id=\"fluffle-dl-1-3\"  data-is-open class=\"wp-block-fluffle-dl-entry\" ><div class=\"wp-block-fluffle-dl-entry-term\" ><h3 class=\"wp-block-fluffle-dl-entry-term-text\" >Data Management<\/h3><\/div><div class=\"wp-block-fluffle-dl-entry-description\" ><div   class=\"wp-block-fluffle-dl is-style-boxed-inner\"><div data-accordion=\"multiple\" data-is-bulleted data-open-mode=\"all-closed\" class=\"wp-block-fluffle-dl-body\" ><details id=\"fluffle-dl-4-1\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >If we are not using Epic, how do we proceed? Do we need to build a registry?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>You can use any data management system you have access to. However, for aggregate analyses, we will use REDCap so we ask that you plan to send us data in a format that can be imported to REDCap (e.g., Excel)<\/p>\n<\/div><\/details><details id=\"fluffle-dl-4-2\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >For Epic will you provide an extraction template used by the study cited to identify DBU from NY or do you expect us to use our own process?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Yes. Mt Sinai will provide the template free of charge, but you\u2019re welcome to use your own if you prefer.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-4-3\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Will you consider the preliminary data on our target population (demographics and how sure we are of their RNA status) beyond just the number of patients? We have a well-defined population we will be targeting though it may not be the highest number of patients.<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>In the absence of better information, we will use the Mt Sinai protocol.<\/p>\n<\/div><\/details><\/div><\/div><\/div><\/section><section id=\"fluffle-dl-1-4\"  data-is-open class=\"wp-block-fluffle-dl-entry\" ><div class=\"wp-block-fluffle-dl-entry-term\" ><h3 class=\"wp-block-fluffle-dl-entry-term-text\" >Other<\/h3><\/div><div class=\"wp-block-fluffle-dl-entry-description\" ><div   class=\"wp-block-fluffle-dl is-style-boxed-inner\"><div data-accordion=\"multiple\" data-is-bulleted data-open-mode=\"all-closed\" class=\"wp-block-fluffle-dl-body\" ><details id=\"fluffle-dl-5-1\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >If there are two Primary Investigators from different organizations and funding is awarded, would the funds be distributed to a single agency to manage and disburse, or would it be divided and sent directly to each organization? Would each organization need to complete its own Agreement and DUA?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Grants can only be awarded to one organization so there needs to be a lead organization or PI, with the other agreeing to the terms agreed to by the first. We do not require separate DUAs unless your institutions require them.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-5-2\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Is Gilead considered a third party sponsor for the grant and\/or will Gilead have rights to any of the data\/results that come from the work? When the deidentified data is shared among other grantees and with CDAF, is that data also reviewed by Gilead?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Gilead is not a third-party sponsor for the grant and will not have access to any data\/results that comes from this work other than what will be available in the public domain (peer review publications and\/or posters and presentations). In addition, Gilead will not review any of the data.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-5-3\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >In Level of Experience, how is &#8220;linked to care&#8221; defined? Does this mean that patients have started treatment for HCV\/HBV or is it to receive a referral to HCV\/HBV services? In Proposal Details, how is &#8220;setting&#8221; defined?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>We define linked to care as the patient seeing a physician with whom they can review treatment options. We define setting, as the different locations where HBV or HCV-infected individuals can access or be referred to care. This includes clinics, hospitals, emergency rooms, prisons, opioid substitution centers or a community setting like immigration centers or homeless shelters.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-5-4\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >What does \u201cDBU\u201d stand for\/mean?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>\u201cDBU\u201d stands for <em>diagnosed but untreated<\/em>.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-5-5\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >Do we need an IRB approval to request and qualify for the grant?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>You do not need IRB approval to qualify for a Relink grant. We do, however, recommend that you follow your organization\u2019s policies about publishing data which might include getting IRB approval.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-5-6\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >How can you claim exemption as a QI intervention and then publish, unless you choose to retrospectively analyze and submit an IRB then?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>See two reference papers, <a rel=\"noreferrer noopener\" href=\"https:\/\/www.nature.com\/articles\/s41598-020-67013-6\" target=\"_blank\">Doyle<\/a> and <a rel=\"noreferrer noopener\" href=\"https:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_5\/S384\/33708166\/jiz694.pdf\" target=\"_blank\">Rowan<\/a> for examples on how two studies circumvented IRB approval requirements. It is also possible to start the program without an IRB and obtain one if needed during the process.<\/p>\n<\/div><\/details><details id=\"fluffle-dl-5-7\"   class=\"wp-block-fluffle-dl-entry\" ><summary class=\"wp-block-fluffle-dl-entry-term\" ><h5 class=\"wp-block-fluffle-dl-entry-term-text\" >If your program already has a robust program for HCV and PLANS to build an internal HBV program, could resources for HBV registry and relinkage be prioritized?<\/h5><\/summary><div class=\"wp-block-fluffle-dl-entry-description\" >\n<p>Yes. The Relink grant is for both HBV and HCV, so you can focus on either one.<\/p>\n<\/div><\/details><\/div><\/div><\/div><\/section><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>We are now accepting applications for the fourth and final round of the CDAF-Relink Grant. Please submit your application and all supporting materials to relink@cdafound.org. The application deadline is November 1st, 2025 (23:59 MT). The RFP, the Application Form, the Budget &amp; Timeline Form, as well as the Contract and the Data Use Agreement (that [&hellip;]<\/p>\n","protected":false},"author":939,"featured_media":7963,"parent":5996,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"subtheme":[368],"class_list":["post-5998","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/users\/939"}],"replies":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/comments?post=5998"}],"version-history":[{"count":33,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5998\/revisions"}],"predecessor-version":[{"id":8662,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5998\/revisions\/8662"}],"up":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/pages\/5996"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/media\/7963"}],"wp:attachment":[{"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/media?parent=5998"}],"wp:term":[{"taxonomy":"subtheme","embeddable":true,"href":"https:\/\/dnc-test.myddns.me\/cda-foundation\/cdafound.org\/wp-json\/wp\/v2\/subtheme?post=5998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}